The glymphatic system is a glial-dependent waste clearance pathway in the central nervous
system, devoted to drain away waste metabolic products and soluble proteins such as …

Next to cancer, Alzheimer's disease (AD) and dementia is probably the most worrying health
problem facing the Western world today. A large number of clinical trials have failed to show …

The global number of people with Alzheimer's disease (AD) doubles every 5 years. It has
been established that unless an effective treatment for AD is found, the incidence of AD will …

Over the last seventy years or so, many previous studies have shown that
photobiomodulation, the use of red to near infrared light on body tissues, can improve …

Molecularly generated light, referred to here as “molecular light”, mainly includes
bioluminescence, chemiluminescence, and Cerenkov luminescence. Molecular light …

Alzheimer's disease (AD) is the most common cause of dementia in the elderly, clinically
defined by progressive cognitive decline and pathologically, by brain atrophy …

Objective: The objective of this review is to consider the dual effects of microbiome and
photobiomodulation (PBM) on human health and to suggest a relationship between these …

Noninvasive transcranial photobiomodulation (tPBM) with a 1064-nm laser has been
reported to improve human performance on cognitive tasks as well as locally upregulate …

Alzheimer's disease (AD), as a neurodegenerative disorder, usually develops slowly but
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …

Background: Photobiomodulation (PBM) involves the use of red and/or near-infrared light
from lasers or LEDs to improve a wide range of medical disorders. Transcranial PBM …